Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Press release: New Chair announced for Committee on the Safety of Devices

Press release

Date: 23 Jan 2009
Time: 12:00
Subject: New Chair for the Committee on the Safety of Devices
Contact: Press Office 020 3080 7651
or press.office@mhra.gsi.gov.uk
Out-of-hours 07770 446 189

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Appointments Commission are pleased to announce the appointment of a new Chairman of the Committee on the Safety of Devices.

Commencing in the post from April 2009, the new Chairman, Dr EJ Perrins BSc MD FRCP FACC, is a consultant cardiologist in Leeds and has vast experience of cardiac devices and procedures.

Beginning his studies in Electrical Engineering at the Imperial College, Dr Perrins then switched to medicine, qualifying with honours from Leeds University in 1975. His postgraduate training was at the Hammersmith and Westminster Hospitals and the National Heart Hospital in London, and in 1985 he was appointed Consultant Cardiologist at the General Infirmary at Leeds.

Dr Perrins has published widely in the fields of cardiac pacing and coronary intervention and has been both the Secretary and Treasurer of Heart Rhythm UK.

Other posts Dr Perrins has held include:

  • President of the British Cardiovascular Intervention society from 1996 to 2000
  • Secretary of the Royal College of Physicians cardiology committee
  • Served on the Clinical Standards Advisory Group (CSAG)
  • Served on the Safety and Efficacy Register for New Interventional Procedures (SERNIP)

Having been appointed to the Committee on the Safety of Devices (CSD) since its formation, Dr Perrins has provided expert advice to the Medical Devices Agency (MDA) now known as the Medicines and Healthcare products Regulatory Agency (MHRA) for many years.

The CSD was established by ministers in 2001 to advise the MHRA on any device related issues as well as carry out annual audits of the device pre-market clinical trial process.

The CSD consists of 25 members from a wide spectrum of clinical specialties, together with allied professional groups including nursing, community pharmacy, laboratory scientists and two lay members.

The Chair is appointed for a four year term renewable for a further four years and is paid an attendance fee of £132 plus a preparation fee of £79 along with travel expenses.

All appointments to the CSD are made on merit with political activity playing no part in the selection process. In accordance with the original Nolan recommendations there is a requirement for an appointee’s political activity to be made public. Dr Perrins has advised he has participated in no political activity during the past five years. He has also stated he has no other ministerial appointments.

Dr Perrins said: “I am greatly honoured to be appointed chair of the CSD as I have remained fascinated by electronics and engineering since my early university career. The complexities of device usage and regulation uniquely blend the two disciplines of clinical medicine and engineering.

“The CSD is a vital resource for the MHRA as the pace of change is far faster in medical devices than in drug development. Responsive regulation and device surveillance is essential to ongoing patient care and safety.”

The CSD appointment has been made in accordance with the Office of the Commissioner for Public Appointments Code of Practice.

Notes to Editor

  • Medical devices are any device used in clinical medicine and includes those sold directly to the public, from heart pacemakers to wheelchairs, X-ray machines to home glucose monitors.
  • The MHRA is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks. We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. We encourage everyone –the public and healthcare professionals as well as the industry – to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action. www.mhra.gov.uk
  • Further information about Dr Perrins can be found at www.johnperrins.com
  • Details of the CSD along with published minutes are available at: http://www.mhra.gov.uk/Committees/Devices/CommitteeontheSafetyofDevices/index.htm
Page last modified: 23 January 2009